Given that A2AR upregulation is associated with decreased cognitive performance characteristic of aging and AD, we studied a rat transgenic model with physiopathological levels of A2AR expression to address the underlying mechanism. The gene discussed is ADORA2A; the disease is Alzheimer disease.